BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28551647)

  • 21. Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.
    Ribeiro C; Campelos S; Moura CS; Machado JC; Justino A; Parente B
    Ann Oncol; 2013 Aug; 24(8):2147-50. PubMed ID: 23585512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant mesothelioma and constitutional BAP1 gene mutations].
    Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R
    Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
    Zauderer MG; Bott M; McMillan R; Sima CS; Rusch V; Krug LM; Ladanyi M
    J Thorac Oncol; 2013 Nov; 8(11):1430-3. PubMed ID: 24128712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus Report of the 2015 Weinman International Conference on Mesothelioma.
    Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S
    J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.
    Mäki-Nevala S; Sarhadi VK; Knuuttila A; Scheinin I; Ellonen P; Lagström S; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuutila S
    Lung; 2016 Feb; 194(1):125-35. PubMed ID: 26463840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
    Alakus H; Yost SE; Woo B; French R; Lin GY; Jepsen K; Frazer KA; Lowy AM; Harismendy O
    J Transl Med; 2015 Apr; 13():122. PubMed ID: 25889843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.
    Boffetta P; Righi L; Ciocan C; Pelucchi C; La Vecchia C; Romano C; Papotti M; Pira E
    Ann Oncol; 2018 Feb; 29(2):484-489. PubMed ID: 29206890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant Mesothelioma and Its Non-Asbestos Causes.
    Attanoos RL; Churg A; Galateau-Salle F; Gibbs AR; Roggli VL
    Arch Pathol Lab Med; 2018 Jun; 142(6):753-760. PubMed ID: 29480760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond.
    Pagliuca F; Zito Marino F; Morgillo F; Della Corte C; Santini M; Vicidomini G; Guggino G; De Dominicis G; Campione S; Accardo M; Cozzolino I; Franco R
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4236-4246. PubMed ID: 34227091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesothelioma families without inheritance of a BAP1 predisposing mutation.
    Ascoli V; Cozzi I; Vatrano S; Izzo S; Giorcelli J; Romeo E; Carnovale-Scalzo C; Grillo LR; Facciolo F; Visca P; Papotti M; Righi L
    Cancer Genet; 2016 Sep; 209(9):381-387. PubMed ID: 27751355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.
    Bahnasy AA; El-Din RS; Sabri NA; Abdel-Rahman CA; Bastawisy AE
    Cancer Genet; 2018 Dec; 228-229():83-92. PubMed ID: 30553477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
    JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant.
    Shinozaki-Ushiku A; Kohsaka S; Kage H; Oda K; Miyagawa K; Nakajima J; Aburatani H; Mano H; Ushiku T
    Pathol Int; 2020 Oct; 70(10):775-780. PubMed ID: 32583627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
    J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated Histogenetic Analysis Reveals
    Bochtler T; Endris V; Reiling A; Leichsenring J; Schweiger MR; Klein S; Stögbauer F; Goeppert B; Schirmacher P; Krämer A; Stenzinger A
    J Natl Compr Canc Netw; 2018 Jun; 16(6):677-682. PubMed ID: 29891518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.